vs

Side-by-side financial comparison of CF BANKSHARES INC. (CFBK) and electroCore, Inc. (ECOR). Click either name above to swap in a different company.

CF BANKSHARES INC. is the larger business by last-quarter revenue ($15.7M vs $9.2M, roughly 1.7× electroCore, Inc.). CF BANKSHARES INC. runs the higher net margin — 40.0% vs -32.8%, a 72.9% gap on every dollar of revenue. On growth, electroCore, Inc. posted the faster year-over-year revenue change (31.2% vs 12.6%). Over the past eight quarters, electroCore, Inc.'s revenue compounded faster (30.3% CAGR vs 13.7%).

CF Bankshares Inc. is a U.S.-based regional bank holding company operating through its community bank subsidiary. It offers a full suite of personal and commercial banking solutions including deposit products, various loan options, wealth management services and digital banking tools, primarily serving individual consumers and small-to-medium business clients across the U.S. Midwest region.

electroCore, Inc. is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation.

CFBK vs ECOR — Head-to-Head

Bigger by revenue
CFBK
CFBK
1.7× larger
CFBK
$15.7M
$9.2M
ECOR
Growing faster (revenue YoY)
ECOR
ECOR
+18.5% gap
ECOR
31.2%
12.6%
CFBK
Higher net margin
CFBK
CFBK
72.9% more per $
CFBK
40.0%
-32.8%
ECOR
Faster 2-yr revenue CAGR
ECOR
ECOR
Annualised
ECOR
30.3%
13.7%
CFBK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CFBK
CFBK
ECOR
ECOR
Revenue
$15.7M
$9.2M
Net Profit
$5.7M
$-3.0M
Gross Margin
88.4%
Operating Margin
43.4%
-31.8%
Net Margin
40.0%
-32.8%
Revenue YoY
12.6%
31.2%
Net Profit YoY
29.9%
6.0%
EPS (diluted)
$0.88
$-0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CFBK
CFBK
ECOR
ECOR
Q4 25
$15.7M
$9.2M
Q3 25
$15.5M
$8.7M
Q2 25
$15.6M
$7.4M
Q1 25
$14.1M
$6.7M
Q4 24
$14.0M
$7.0M
Q3 24
$13.1M
$6.6M
Q2 24
$12.6M
$6.1M
Q1 24
$12.2M
$5.4M
Net Profit
CFBK
CFBK
ECOR
ECOR
Q4 25
$5.7M
$-3.0M
Q3 25
$2.3M
$-3.4M
Q2 25
$5.0M
$-3.7M
Q1 25
$4.4M
$-3.9M
Q4 24
$4.4M
$-3.2M
Q3 24
$4.2M
$-2.5M
Q2 24
$1.7M
$-2.7M
Q1 24
$3.1M
$-3.5M
Gross Margin
CFBK
CFBK
ECOR
ECOR
Q4 25
88.4%
Q3 25
86.0%
Q2 25
87.3%
Q1 25
84.9%
Q4 24
85.9%
Q3 24
83.8%
Q2 24
86.3%
Q1 24
83.7%
Operating Margin
CFBK
CFBK
ECOR
ECOR
Q4 25
43.4%
-31.8%
Q3 25
17.5%
-33.2%
Q2 25
41.1%
-47.5%
Q1 25
39.5%
-56.9%
Q4 24
36.9%
-43.6%
Q3 24
40.4%
-40.4%
Q2 24
15.4%
-42.2%
Q1 24
30.9%
-70.7%
Net Margin
CFBK
CFBK
ECOR
ECOR
Q4 25
40.0%
-32.8%
Q3 25
15.1%
-39.2%
Q2 25
32.3%
-49.7%
Q1 25
31.4%
-57.4%
Q4 24
35.2%
-45.8%
Q3 24
32.2%
-38.1%
Q2 24
13.5%
-43.2%
Q1 24
25.2%
-64.4%
EPS (diluted)
CFBK
CFBK
ECOR
ECOR
Q4 25
$0.88
$-0.34
Q3 25
$0.36
$-0.40
Q2 25
$0.77
$-0.44
Q1 25
$0.68
$-0.47
Q4 24
$0.68
$-0.37
Q3 24
$0.65
$-0.31
Q2 24
$0.26
$-0.38
Q1 24
$0.47
$-0.53

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CFBK
CFBK
ECOR
ECOR
Cash + ST InvestmentsLiquidity on hand
$259.0M
$11.6M
Total DebtLower is stronger
$7.8M
Stockholders' EquityBook value
$184.4M
$-1.7M
Total Assets
$2.1B
$18.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CFBK
CFBK
ECOR
ECOR
Q4 25
$259.0M
$11.6M
Q3 25
$272.4M
$13.0M
Q2 25
$275.7M
$7.1M
Q1 25
$241.0M
$7.8M
Q4 24
$235.3M
$12.2M
Q3 24
$233.5M
$12.9M
Q2 24
$241.8M
$14.2M
Q1 24
$236.9M
$7.8M
Total Debt
CFBK
CFBK
ECOR
ECOR
Q4 25
$7.8M
Q3 25
$7.8M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CFBK
CFBK
ECOR
ECOR
Q4 25
$184.4M
$-1.7M
Q3 25
$179.3M
$-1.1M
Q2 25
$177.0M
$1.1M
Q1 25
$172.7M
$4.4M
Q4 24
$168.4M
$7.5M
Q3 24
$164.0M
$9.5M
Q2 24
$159.6M
$11.5M
Q1 24
$158.0M
$4.5M
Total Assets
CFBK
CFBK
ECOR
ECOR
Q4 25
$2.1B
$18.7M
Q3 25
$2.1B
$21.4M
Q2 25
$2.1B
$14.6M
Q1 25
$2.1B
$16.0M
Q4 24
$2.1B
$20.5M
Q3 24
$2.1B
$21.0M
Q2 24
$2.0B
$22.4M
Q1 24
$2.0B
$13.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CFBK
CFBK
ECOR
ECOR
Operating Cash FlowLast quarter
$18.7M
$-1.5M
Free Cash FlowOCF − Capex
$18.2M
FCF MarginFCF / Revenue
115.6%
Capex IntensityCapex / Revenue
3.1%
0.0%
Cash ConversionOCF / Net Profit
3.26×
TTM Free Cash FlowTrailing 4 quarters
$33.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CFBK
CFBK
ECOR
ECOR
Q4 25
$18.7M
$-1.5M
Q3 25
$5.5M
$-1.7M
Q2 25
$8.0M
$-623.0K
Q1 25
$2.2M
$-4.4M
Q4 24
$14.2M
$-1.3M
Q3 24
$-1.3M
$-1.4M
Q2 24
$4.0M
$-1.8M
Q1 24
$-1.2M
$-2.6M
Free Cash Flow
CFBK
CFBK
ECOR
ECOR
Q4 25
$18.2M
Q3 25
$5.2M
$-1.7M
Q2 25
$7.8M
$-648.0K
Q1 25
$2.2M
$-4.4M
Q4 24
$13.9M
Q3 24
$-1.3M
Q2 24
$4.0M
Q1 24
$-1.2M
FCF Margin
CFBK
CFBK
ECOR
ECOR
Q4 25
115.6%
Q3 25
33.6%
-19.3%
Q2 25
50.3%
-8.8%
Q1 25
15.2%
-65.4%
Q4 24
99.6%
Q3 24
-9.9%
Q2 24
31.6%
Q1 24
-9.5%
Capex Intensity
CFBK
CFBK
ECOR
ECOR
Q4 25
3.1%
0.0%
Q3 25
1.7%
0.0%
Q2 25
0.7%
0.3%
Q1 25
0.4%
0.6%
Q4 24
1.9%
Q3 24
0.2%
Q2 24
0.1%
Q1 24
0.0%
Cash Conversion
CFBK
CFBK
ECOR
ECOR
Q4 25
3.26×
Q3 25
2.34×
Q2 25
1.58×
Q1 25
0.50×
Q4 24
3.21×
Q3 24
-0.30×
Q2 24
2.35×
Q1 24
-0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons